FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

895362005: Belantamab mafodotin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4029064012 Belantamab mafodotin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4029065013 Belantamab mafodotin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Belantamab mafodotin Is a Monoclonal antibody true Inferred relationship Some
Belantamab mafodotin Is a Antineoplastic agent (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing belantamab mafodotin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Belantamab mafodotin Inferred relationship Some 1
Belantamab mafodotin only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Belantamab mafodotin Inferred relationship Some 1
Product containing belantamab mafodotin in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Belantamab mafodotin Inferred relationship Some 1
Product containing only belantamab mafodotin in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Belantamab mafodotin Inferred relationship Some 1
Belantamab mafodotin therapy (procedure) Direct substance True Belantamab mafodotin Inferred relationship Some 1

This concept is not in any reference sets

Back to Start